Description
WRP-2 TR is a synthetic linear peptide composed of 39 amino acids based primarily on the human gastric inhibitory polypeptide (GIP) sequence, featuring non-coded α-aminoisobutyric acid (Aib) residues at positions 2 and 13 and an attached C20 fatty diacid chain at lysine 20. WRP-2 TR is novel medication that acts as a dual agonist for the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor.
Product Specifications
Compound: WRP-2 TR
Format: Lyophilized Powder
Volume: Please see label for specific product details.
Purity Standard: >99%
Product Testing: Independently verified by a 3rd party lab in the USA.









